FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA Guidances for Generic Drug Developers

[ Price : $8.95]

Federal Register notice: FDA makes available additional draft and revised draft product-specific guidances for generic drug develo...

Info Collection for Fellowship/Trainee Programs

[ Price : $8.95]

Federal Register notice: FDA seeks comments on a proposed information collection for Collection of Information for Participation i...

Guide on Insulin Biosimilar Immunogenicity

[ Price : $8.95]

FDA issues a draft guidance on Clinical Immunogenicity Considerations for Biosimilar and Interchangeable Insulin Products.

Renovia Next-Gen Leva Pelvic Therapeutic Cleared

[ Price : $8.95]

FDA clears a Renovia 510(k) for its next-generation Leva Pelvic Digital Therapeutic for strengthening pelvic floor muscles and tre...

Complete Response on Adamis High-Dose Naloxone

[ Price : $8.95]

FDA issues Adamis Pharmaceuticals a complete response letter on its NDA for Adamis ZimHi (naloxone) high-dose injection for treati...

OPDP Hits Triferic Web Page Promotion

[ Price : $8.95]

CDER Office of Prescription Drug Promotion sends Rockwell Medical an untitled letter after reviewing the companys Triferic Web pag...

FDA Reopens Tobacco Product Comment Period

[ Price : $8.95]

Federal Register notice: FDA reopens for 20 days the comment period on a 9/25 proposed rule on premarket tobacco product applicati...

Intercept NDA for NASH Drug Accepted

[ Price : $8.95]

FDA accepts for priority review an Intercept Pharmaceuticals NDA for obeticholic acid seeking accelerated approval for treating fi...

Draft Guide on Certificates of Confidentiality

[ Price : $8.95]

Federal Register notice: FDA has made available a draft guidance entitled Certificates of Confidentiality; Guidance for Sponsors, ...

Endo BLA Accepted for Cellulite Therapy

[ Price : $8.95]

FDA accepts for review an Endo International BLA for collagenase clostridium histolyticum (CCH) for treating cellulite in the butt...